This section contains not only general information but also information dealing with the company's follow-up obligations as part of the membership in a certain transparency standard at Börse Frankfurt, FWB, the Frankfurt Stock Exchange. This mandatory information is marked with an asterisk. Learn more about what information is required depending on transparency standard and asset class on deutsche-boerse-cash-market.com.
- About the Company
- Corporate Information
- Last Company Report Submitted
- Corporate Calendar
- Shareholder Structure
- IPO Company Data
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
|Phone||+49 (0)451 882-0|
|Fax||+49 (0)451 882-2080|
About the Company
'Technology for Life' is our guiding principle and our mission. Wherever they are deployed - in clinical settings, industry, mining or emergency services - Dräger products protect, support and save lives.
Dräger Safety offers its customers complete hazard management solutions with a special focus on personal safety and protecting production facilities. The Safety division's current portfolio includes stationary and mobile gas detection systems, respiratory protection, firefighting equipment, professional diving gear, and alcohol and drug-testing instruments.
The Medical division's product range covers anesthesia workstations, ventilation equipment for intensive and home care, emergency and mobile ventilation units, warming therapy equipment for infants, patient monitoring equipment, IT solutions and gas management systems.
Dräger has nearly 13,500 employees worldwide and is present in over 190 countries around the globe. The Group maintains sales and service organizations in over 50 countries. Dräger's development and production facilities are located in Germany, Great Britain, Sweden, South Africa, the United States, Brazil, Czech Republic and China.
|Transparency Standard||Prime Standard|
|Market Segment||Regulated Market|
|End of Business Year||31/12/|
|Total Capital Stock||€ 45,465,600.00|
|Executive Board||Stefan Dräger (Chairman), Gert Hartwig Lescow, Toni Schrofner|
Dr. Nikolaus Schweickart (Chairman), Siegfried Kasang* (Vice Chairman), Daniel Friedrich*, Dr. Thorsten Grenz, Uwe Lüders, Bernd Mußmann*, Walter Neundorf*, Regina Pawils, Jürgen Peddinghaus, Dr. Klaus Rauscher, Thomas Rickers*, Ulrike Tinnefeld*, Dr. Reinhard Zinkann
|Last Payment Date||Dividend Cycle||Amount||ISIN|
IPO Company Data
* Please note: Companies may address supplementary questions regarding the submission of mandatory data marked with an * by sending an e-mail to: email@example.com, phone: +49-(0) 69-2 11-1 31 87.